A new study led by Associate Professor Ghada Soliman examines how the mechanistic target of Rapamycin (mTOR) protein regulates nutrient metabolism and glucose homeostasis in humans.
Aug 30, 2022
0
11
Pancreatic cancer has few treatment options and limited survival, with only 9% of patients still living five years after diagnosis.
Aug 22, 2022
0
66
In type 1 diabetes, the body develops immune cells that target pancreatic beta cells, which play a critical role in the production and secretion of insulin. One of the earliest targets of this immune response is a specific ...
Jul 25, 2022
0
130
A world-first study by Monash University, in Melbourne, Australia has discovered a pathway to the regeneration of insulin in pancreatic stem cells, a major breakthrough toward new therapies to treat Type 1 and Type 2 diabetes.
Jul 22, 2022
0
215
Scientists have shown it is possible to reverse a key process that allows pancreatic cancer cells to grow and spread around the body.
Jun 29, 2022
0
223
More than 62,000 people in the United States will be diagnosed with pancreatic cancer by the end of this year, with the vast majority having a deadly and aggressive subtype known as pancreatic ductal adenocarcinoma (PDA). ...
Jun 27, 2022
0
73
Calcium channel blockers may improve treatment for pancreatic cancer patients receiving gemcitabine-based chemotherapy, according to recent findings published in the Proceedings of the National Academy of Sciences.
Jun 22, 2022
0
68
The lab of Kathy DelGiorno, assistant professor of cell and developmental biology, seeks to understand changes in the pancreas in response to injury and disease. In a recent project led by graduate student Leah Caplan, also ...
Jun 17, 2022
0
14
About 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to diabetes each year, according to the World Health Organization. Type 1 diabetes is a chronic condition in which the insulin-producing ...
Jun 14, 2022
0
73
Researchers have successfully treated type 1 diabetes in mice using pancreatic beta-cell, target-specific, chimeric antigen-receptor (CAR) regulatory T cells (Tregs), and demonstrated the feasibility of their approach to ...
Jun 13, 2022
0
15
